Skip to main content

Peer Review reports

From: The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry

Original Submission
25 Oct 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Dec 2022 Reviewed Reviewer Report
28 Dec 2022 Reviewed Reviewer Report
28 Jan 2023 Author responded Author comments - Marianna Štefaniková
Resubmission - Version 3
28 Jan 2023 Submitted Manuscript version 3
2 Feb 2023 Author responded Author comments - Marianna Štefaniková
Resubmission - Version 4
2 Feb 2023 Submitted Manuscript version 4
4 Feb 2023 Author responded Author comments - Marianna Štefaniková
Resubmission - Version 5
4 Feb 2023 Submitted Manuscript version 5
8 Feb 2023 Reviewed Reviewer Report
23 Feb 2023 Reviewed Reviewer Report
8 Mar 2023 Author responded Author comments - Marianna Štefaniková
Resubmission - Version 6
8 Mar 2023 Submitted Manuscript version 6
22 Mar 2023 Reviewed Reviewer Report
15 Apr 2023 Author responded Author comments - Marianna Štefaniková
Resubmission - Version 7
15 Apr 2023 Submitted Manuscript version 7
19 Apr 2023 Author responded Author comments - Marianna Štefaniková
Resubmission - Version 8
19 Apr 2023 Submitted Manuscript version 8
Publishing
23 Apr 2023 Editorially accepted
3 May 2023 Article published 10.1186/s12890-023-02450-3

You can find further information about peer review here.

Back to article page